In recent years, companion animals have come to occupy an increasingly significant role in human life—not merely as pets, but as integral members of the family. As pet owners place growing emphasis on animal health and longevity, the demand for functional health ingredients has surged. Among these, fucoidan, a marine-derived polysaccharide extracted from brown seaweed, has emerged as a key player in the field of pet nutritional science. Recognized for its immunomodulatory, antioxidant, and cellular repair properties, fucoidan is redefining the standards for preventive care and holistic wellness in companion animals.

In the rapidly developing digital era, healthcare is being profoundly transformed by Artificial Intelligence (AI), the Internet of Things (IoT), and wearable devices. This is not just a technological upgrade; it is akin to the "iPhone moment" that disrupted traditional healthcare services and doctor-patient interactions, opening a new chapter in health management. Historically, medicine has been a "passive" journey fraught with uncertainty and high barriers. The powerful rise of AI is now painting a new blueprint for the global healthcare industry, steering health management toward a smarter and more personalized future.

From the inception of a new drug to its market launch, the process demands astronomical investments, prolonged development timelines, and faces countless risks at every stage. For decades, pharmaceutical companies have struggled along this arduous path, with many promising drugs failing to reach patients. However, the rise of artificial intelligence (AI) is ushering in a transformative era, disrupting traditional drug development paradigms. AI not only streamlines R&D workflows but also reshapes the global landscape of capital and innovation competition.

In 2025, the global healthcare system faces the dual challenges of a surge in chronic diseases and an aging population. The focus is shifting from treating a single illness to promoting holistic health. In the post-pandemic era, the demand for mental health services has risen sharply, with a continuous increase in the number of people suffering from anxiety and depression. To meet this challenge, healthcare institutions are actively adopting a dual-track strategy, focusing on expanding behavioral health services and ensuring seamless transitions to post-acute care. This approach is designed to enhance the continuity of patient care and improve long-term health outcomes.

In pursuit of a fast-paced life, we often overlook our body's warning signs. According to the Health Promotion Administration, Ministry of Health and Welfare, chronic diseases like hypertension and diabetes have become a hidden threat to public health. Though these conditions progress slowly, long-term neglect can lead to serious consequences such as heart disease or stroke. This article will help you understand their causes and provide a simple “self-health management process” to proactively take control of your health.

As the demand for medical and health care continues to rise, YOHO Medical Enterprise Co., Ltd. (YOHO Medical) leverages its years of professional medical consumables manufacturing experience. It extends the strict standards of professional healthcare to various aspects of life, carefully creating five product lines covering professional medical, mother and baby care, medical beauty care, home and pet supplies, and industrial equipment. YOHO Medical adheres to strict manufacturing standards and excellent quality, continuously meeting diverse market demands and solidifying its trustworthy brand image.

The medical industry environment is rapidly changing, where technological innovation and strict regulatory management have become the twin drivers of continuous corporate growth. Cambus Corporation deeply understands the importance of international medical device regulations and the ISO 13485 quality management system, viewing rigorous compliance as a strategic cornerstone for enhancing product quality and market competitiveness. By utilizing a systematic and stringent quality management framework, Cambus successfully transforms compliance challenges into a competitive advantage, effectively helping clients increase product value and accelerate product launch.

Plastics play a central role in modern healthcare—from syringes and IV bags to protective barriers and diagnostic equipment. These materials ensure sterility, low cost, and single-use safety, but their widespread usage also creates major sustainability and health challenges.

In the context of the global manufacturing industry's ongoing transformation and upgrading, plastic injection molding has become an indispensable link in the supply chain and a key factor for brands to create product differentiation and seize market opportunities. Since its establishment in 1974, Shin Fang Plastic Industrial Co., Ltd. has leveraged over fifty years of industry experience to offer diverse plastic part solutions from product design to mass production, helping customers capture market advantages. This article delves into Shin Fang’s core values in injection manufacturing, customization capabilities, and its new approach amid smart manufacturing and sustainability trends, demonstrating its solid strength as a leading OEM/ODM plastic part manufacturer.

Founded in 1986, GaleMed has been deeply engaged in the global respiratory care market under the GaleMed brand since 1996. It has now become a leading manufacturer of medical respiratory interface technologies. The company offers a comprehensive product line covering seven major areas: emergency rescue, respiratory therapy, anesthesia, oxygen therapy, aerosol therapy, sleep management, and more. Headquartered in Yilan, Taiwan, GaleMed provides over 5,000 SKUs marketed to more than 100 countries worldwide. Since 1995, the company has obtained multiple rigorous international certifications including ISO 9001, EN 46001, and CE. In 2024, GaleMed successfully achieved the European Union Medical Device Regulation (MDR) certification, demonstrating its professional expertise and commitment to sustainable operations.

When a patient experiences respiratory arrest—such as cardiac arrest, choking, or unconsciousness—failure to provide immediate oxygen or effective ventilation can lead to prolonged brain hypoxia and irreversible damage. This risk is especially pronounced in situations lacking oxygen tanks, powered equipment, or in remote areas and disaster sites, where traditional rescue methods are often limited. First responders frequently lack access to devices that provide isolation and positive pressure ventilation capabilities.

Pulmonary rehabilitation has been internationally recognized by respiratory medical organizations as a core component in managing chronic respiratory diseases. Its purpose is to enhance respiratory muscle endurance, ventilation efficiency, and daily functional capacity, thereby reducing hospitalization risk and improving quality of life. Patients experiencing respiratory muscle imbalance, alveolar collapse, or mucus accumulation—such as postoperative patients, those with COPD, neurodegenerative diseases, or recovering from COVID-19—can achieve stabilized respiratory function through systematic training combined with assistive devices.

For patients with hypoxemia, dyspnea, or pneumonia, simple oxygen therapy alone may not effectively alleviate inflammatory responses or breathing difficulties. Combining aerosolized medication nebulization with oxygen humidification can promote pulmonary ventilation, improve secretion clearance, and relieve symptoms. This strategy is widely applied in chronic obstructive pulmonary disease (COPD), long-term oxygen therapy patients, postoperative care, acute and chronic respiratory infections, and post-COVID-19 rehabilitation stages. It achieves synergistic effects of oxygen supplementation combined with bronchodilators or saline nebulization, enhancing overall respiratory function and patient comfort.

When a patient experiences respiratory arrest—such as cardiac arrest, choking, or coma—if oxygen or effective ventilation cannot be promptly provided, prolonged brain hypoxia may result in irreversible damage. Particularly in scenarios without oxygen tanks, power sources, or in remote or disaster-stricken areas, traditional rescue methods face many limitations. Rescuers often lack equipment that provides isolation and positive-pressure ventilation. In such cases, a manual resuscitation bag can supply oxygen under pressure, maintaining patient life even without an oxygen source. This device is portable, easy to use, and requires no setup.

In today’s rapidly advancing digital landscape, mobile devices have evolved beyond mere reference tools to become integral extensions of professional workflows. Particularly in sectors such as healthcare, education, and logistics, heightened post-pandemic demands for efficiency and safety have driven the emergence of new tablet cart solutions characterized by mobility, adjustability, and integration. These mobile tablet carts—featuring pneumatic height adjustment, multi-directional swivel mounts, and all-in-one designs—are setting new standards for mobile work platforms. They enable users to seamlessly transition from a single device to a fully functional workstation, significantly enhancing professional productivity and user experience.

With the growing adoption of telemedicine and real-time monitoring systems, medical carts have evolved beyond their traditional role as transport tools—transforming into intelligent platforms that integrate connectivity and information display capabilities. These carts support uninterrupted clinical workflows, enabling healthcare professionals to update medical records, operate medical devices, and perform emergency interventions efficiently. Against this backdrop, various types of medical carts—including medication carts, emergency carts, and equipment-integrated carts—are moving toward intelligent and highly modular designs, significantly enhancing clinical efficiency and the overall quality of patient care.

The evolution of healthcare is a continuous response to the needs of the times. Breathing masks, a medical consumable we once paid little attention to, are a concrete example of this transformative wave. They are shifting from being a cold, professional tool to a gentle companion infused with intelligence and human-centered care.

The global medical monitor mount market is experiencing steady growth. Driven by the widespread adoption of medical imaging technologies, the rising demand for minimally invasive surgeries, and the increasing digitization of nursing stations and bedside workflows, clinical settings are showing a strong need for mounts that combine high flexibility, ergonomic adjustability, and hygienic design. In 2024, the market size is estimated to reach USD 1.2 to 1.25 billion, with projections indicating growth to USD 2 to 2.5 billion by 2033—representing a compound annual growth rate (CAGR) of 7% to 9%. Amid this trend, medical monitor mounts are evolving toward enhanced ergonomics, integrated cable management, antimicrobial materials, and diversified mounting solutions to meet the high standards of safety, efficiency, and durability required by modern healthcare facilities.

In medical settings, everything from the operation of monitoring devices to the movement of hospital beds impacts both the efficiency of healthcare teams and the quality of patient care. Diwei Technology offers six meticulously designed product categories—monitor arms, medical carts, equipment carts, medication carts, emergency carts, and mobile stretcher carts—providing comprehensive, integrated, and intelligently optimized solutions tailored to diverse clinical needs.

Walk into a modern veterinary hospital today and you'll find a striking sight: technology once exclusive to human medicine—from advanced CT scanners to sophisticated physical therapy rooms—is now standard practice. This isn't just simple borrowing; it's a profound medical revolution that is fundamentally changing how we diagnose, treat, and care for the animals we love.